Zacks Investment Research
13 Nov 2026, 09:41 UTC · 2h ago
New Strong Sell Stocks for November 13th
Impact · against what's priced in
The reported downward earnings revisions for BROS, XRAY, and GECC are largely expected or systemic adjustments. For Dutch Bros, this aligns with a market that has already rejected aggressive growth targets, while for the others, the updates serve as negative confirmations of deteriorating estimates.
- BROS−0.10
Already priced in
- The price assumes
the market has explicitly rejected the aggressive growth these targets require and is pricing in a sharp deceleration
The 5.2% downward revision in earnings estimates reinforces the current price's rejection of aggressive growth targets and its assumption of a deceleration.
What BROS's price assumes · Sep 2
